Pål Berg-Hansen
Position: Ass. prof, consultant of neurology, MD, PhD
Phone: +47 221 19926
Email:

Address: Department of Neurology, Oslo University Hospital and University of Oslo, 0407 Oslo, Norway

 

Background:
Pål Berg-Hansen has a medical degree from University of Oslo (UiO) from 1998 and is a specialist in neurology from 2007. He is a senior consultant at the Department of Neurology, Oslo University Hospital with a special interest in MS patients and attended the PhD-project in January 2012.

PhD-project:
The title of his PhD thesis is "Clinical and epidemiological studies of immigrants with multiple sclerosis in Norway ."
In the first part of the project he is studying differences in disease severity and oligoclonal band status between different ethnical groups with MS in Oslo. The second part is a registry based prevalence study of immigrant groups in Norway, where differences in disease severity is measured by prescription of disease modifying drugs.

Main supervisor: Elisabeth Gulowsen Celius (MD, PhD.)
Co-supervisors: Hanne F. Harbo (MD, PhD) and Stine Marit Moen (MD, PhD).

Research interests:
• Epidemiology
• Migration studies
• Clinical studies
• Environmental factors associated with MS
• Biomarkers

 

Author network for Pål Berg-Hansen by COREMINE medical


Publications 2016

Berg-Hansen P (2016)
[Not Available]
Tidsskr Nor Laegeforen, 136 (2), 157
PubMed 26813826

Simonsen CS, Edland A, Berg-Hansen P, Celius EG (2016)
High prevalence and increasing incidence of multiple sclerosis in the Norwegian county of Buskerud
Acta Neurol Scand (in press)
PubMed 27241360

Publications 2015

Berg-Hansen P, Celius EG (2015)
Socio-economic factors and immigrant population studies of multiple sclerosis
Acta Neurol Scand, 132 (199), 37-41
PubMed 26046557

Berg-Hansen P, Moen SM, Harbo HF, Celius EG (2015)
Comments on the review article 'Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades'
Acta Neurol Scand, 132 (5), 364-7
PubMed 26423981

Goris A, Pauwels I, Gustavsen MW, van Son B, Hilven K, Bos SD, Celius EG, Berg-Hansen P, Aarseth J, Myhr KM, D'Alfonso S, Barizzone N, Leone MA, Martinelli Boneschi F, Sorosina M, Liberatore G, Kockum I, Olsson T, Hillert J, Alfredsson L, Bedri SK, Hemmer B, Buck D, Berthele A, Knier B et al. (2015)
Genetic variants are major determinants of CSF antibody levels in multiple sclerosis
Brain, 138 (Pt 3), 632-43
PubMed 25616667

Publications 2014

Berg-Hansen P, Moen SM, Harbo HF, Celius EG (2014)
High prevalence and no latitude gradient of multiple sclerosis in Norway
Mult Scler, 20 (13), 1780-2
PubMed 24603884

Berg-Hansen P, Moen SM, Sandvik L, Harbo HF, Bakken IJ, Stoltenberg C, Celius EG (2014)
Prevalence of multiple sclerosis among immigrants in Norway
Mult Scler, 21 (6), 695-702
PubMed 25344371

Gustavsen MW, Celius EG, Moen SM, Bjølgerud A, Berg-Hansen P, Nygaard GO, Sandvik L, Lie BA, Harbo HF (2014)
No association between multiple sclerosis and periodontitis after adjusting for smoking habits
Eur J Neurol, 22 (3), 588-90
PubMed 25041906

Gustavsen MW, Page CM, Moen SM, Bjølgerud A, Berg-Hansen P, Nygaard GO, Sandvik L, Lie BA, Celius EG, Harbo HF (2014)
Environmental exposures and the risk of multiple sclerosis investigated in a Norwegian case-control study
BMC Neurol, 14, 196
PubMed 25274070

Gustavsen MW, Viken MK, Celius EG, Berge T, Mero IL, Berg-Hansen P, Aarseth JH, Myhr KM, Søndergaard HB, Sellebjerg F, Oturai AB, Hillert J, Alfredsson L, Olsson T, Kockum I, Lie BA, Harbo HF (2014)
Oligoclonal band phenotypes in MS differ in their HLA class II association, while specific KIR ligands at HLA class I show association to MS in general
J Neuroimmunol, 274 (1-2), 174-9
PubMed 25037176

Publications 2013

Berg-Hansen P, Smestad C, Sandvik L, Harbo HF, Celius EG (2013)
Increased disease severity in non-Western immigrants with multiple sclerosis in Oslo, Norway
Eur J Neurol, 20 (12), 1546-52
PubMed 23834430

Harbo HF, Isobe N, Berg-Hansen P, Bos SD, Caillier SJ, Gustavsen MW, Mero IL, Celius EG, Hauser SL, Oksenberg JR, Gourraud PA (2013)
Oligoclonal bands and age at onset correlate with genetic risk score in multiple sclerosis
Mult Scler, 20 (6), 660-8
PubMed 24099750

Mero IL, Gustavsen MW, Sæther HS, Flåm ST, Berg-Hansen P, Søndergaard HB, Jensen PE, Berge T, Bjølgerud A, Muggerud A, Aarseth JH, International Multiple Sclerosis Genetics Consortium, Myhr KM, Celius EG, Sellebjerg F, Hillert J, Alfredsson L, Olsson T, Oturai AB, Kockum I, Lie BA, Andreassen BK, Harbo HF (2013)
Oligoclonal band status in Scandinavian multiple sclerosis patients is associated with specific genetic risk alleles
PLoS One, 8 (3), e58352
PubMed 23472185

Publications 2012

Nilsen KB, Berg-Hansen P, Berge E, Petterson MA, Gjesdal K (2012)
[A man with debilitating orthostatic hypotension]
Tidsskr Nor Laegeforen, 132 (15), 1758-61
PubMed 22929944

Publications 2010

Holmøy T, Wilson JA, von der Lippe C, Andersen PM, Berg-Hansen P (2010)
G127R: A novel SOD1 mutation associated with rapidly evolving ALS and severe pain syndrome
Amyotroph Lateral Scler, 11 (5), 478-80
PubMed 20192886

Publications 2009

Berg-Hansen P, Vandvik B, Fagerhol M, Holmøy T (2009)
Calprotectin levels in the cerebrospinal fluid reflect disease activity in multiple sclerosis
J Neuroimmunol, 216 (1-2), 98-102
PubMed 19800696